Market at a Crossroads: Key Signals, Portfolio Moves & My First eBook!
February 9, 2025 - Update
Market & Portfolio Update
MACRO OUTLOOK: Walking a Fine Line
The market is sending mixed signals:
Monetary policy remains tight. M2 money supply isn’t growing, signaling the FED's focus on stabilizing prices. I want to see M2 rising again soon.
Inflation is improving. I expect next week’s data to surprise positively. The January CPI should be slightly better than December, and February better than January.
The economy remains strong. Q1 2025 GDP growth is forecasted at 3.1%—a solid pace.
The 10-year Treasury yield has been declining since mid-January, easing financial conditions.
What to Watch:
The ideal scenario? Better-than-expected inflation, strong earnings, solid guidance, and moderate economic data. This mix could push the FED to start cutting rates.
Risks to avoid:
Bad inflation data. If inflation spikes again, rate cuts could be delayed.
Banks tightening credit. Restrictive lending would hurt market momentum.
Market Technicals:
NASDAQ Daily Chart: Looking weak—trading below the 50-day moving average with the 20-day SMA flattening.
NASDAQ Weekly Chart: Still bullish. If inflation data comes in strong, we could see a reversal back up.
PORTFOLIO UPDATES
10X MOMENTUM PORTFOLIO
📌 Start Date: April 2023 – Initial Capital: $10K
📌 Focus: High-growth, high-quality stocks without overvaluation
📌 Strategy: Ride bullish trends over weeks/months
📌 Risk Management: Tighter stop losses (~15%)
📌 ROI to Date: +161% (68% annualized)
Last Week’s Moves:
✅ BUY STOP orders triggered for:
CART (Maplebear Inc.)
META (Meta Inc.)
📌 Stop Loss levels updated
🚫 No new buy orders this week
10X UNDERPRICED GROWTH PORTFOLIO
📌 Start Date: Sept 15, 2024 – Initial Capital: $100K
📌 Focus: High-growth, undervalued companies
📌 Strategy: Up to 10 positions with wide stop losses (25–30%)
📌 ROI to Date: +13.5% (37% annualized)
📌 Goal: Explosive growth in strong markets
Last Week’s Moves:
✅ BUY STOP order triggered for:
LFMD (LifeMed Inc.)
✅ Stop Loss triggered for:
SOFI (SoFi Technologies Inc.) (+49% gain)
ARQT (Arcutis Biotherapeutics Inc.) (-11% and -23% losses on separate positions)
📌 Stop Loss levels updated
🚫 No new buy orders this week
🚀 Exciting News: My First eBook is Here!
I’m thrilled to release my first-ever eBook! 📘 Inside, I break down my strategy for finding high-quality, undervalued stocks with strong upside potential.
📈 What’s Inside?
✅ 5 high-potential stock picks every month
✅ A structured, transparent investing approach
✅ Market insights to invest with confidence
🔗 Download now and share my journey! [Download pdf Link]
📌 For Paid Subscribers: The eBook is included in your Substack subscription.
📌 First edition is FREE for everyone! Feel free to share it!
That’s it for this week!
Enjoy my content? Hit the Like button, thanks!
⚠️ Disclaimer: Not financial advice. Consult a professional before investing.